These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 6285713)

  • 1. Neonatal acyclovir pharmacokinetics in patients with herpes virus infections.
    Hintz M; Connor JD; Spector SA; Blum MR; Keeney RE; Yeager AS
    Am J Med; 1982 Jul; 73(1A):210-4. PubMed ID: 6285713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of herpes virus infections in immunocompromised patients with acyclovir by continuous intravenous infusion.
    Spector SA; Hintz M; Wyborny C; Connor JD; Keeney RE; Liao S
    Am J Med; 1982 Jul; 73(1A):275-80. PubMed ID: 6285719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of acyclovir in humans following intravenous administration. A model for the development of parenteral antivirals.
    Whitley RJ; Blum MR; Barton N; de Miranda P
    Am J Med; 1982 Jul; 73(1A):165-71. PubMed ID: 7102700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of acyclovir in premature and term neonates.
    Yeager AS
    Am J Med; 1982 Jul; 73(1A):205-9. PubMed ID: 6285712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro and in vivo responses of cytomegalovirus to acyclovir.
    Plotkin SA; Starr SE; Bryan CK
    Am J Med; 1982 Jul; 73(1A):257-61. PubMed ID: 6285717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acyclovir treatment of herpes simplex virus infections in immunocompromised humans. An overview.
    Alford CA
    Am J Med; 1982 Jul; 73(1A):225-8. PubMed ID: 6285714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human pharmacokinetics of acyclovir (an antiviral agent) following rapid intravenous injection.
    Brigden D; Bye A; Fowle AS; Rogers H
    J Antimicrob Chemother; 1981 Apr; 7(4):399-404. PubMed ID: 7251524
    [No Abstract]   [Full Text] [Related]  

  • 8. [Experiences with intravenously administered acyclovir in severe herpesvirus infections].
    van der Meer JW; Versteeg J
    Ned Tijdschr Geneeskd; 1981 Nov; 125(48):1953-8. PubMed ID: 6273756
    [No Abstract]   [Full Text] [Related]  

  • 9. Single-dose pharmacokinetics of acyclovir.
    Spector SA; Connor JD; Hintz M; Quinn RP; Blum MR; Keeney RE
    Antimicrob Agents Chemother; 1981 Apr; 19(4):608-12. PubMed ID: 7247383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of orally administered acyclovir in patients with herpes progenitalis.
    Van Dyke RB; Connor JD; Wyborny C; Hintz M; Keeney RE
    Am J Med; 1982 Jul; 73(1A):172-5. PubMed ID: 7102701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acyclovir tolerance in humans.
    Keeney RE; Kirk LE; Bridgen D
    Am J Med; 1982 Jul; 73(1A):176-81. PubMed ID: 6285709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Uptake, distribution, and anabolism of acyclovir in herpes simplex virus-infected mice.
    Biron KK; Noblin JE; de Miranda P; Elion GB
    Antimicrob Agents Chemother; 1982 Jan; 21(1):44-50. PubMed ID: 7081975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimal treatment of herpes simplex virus encephalitis in mice with oral acyclovir.
    Kern ER; Richards JT; Glasgow LA; Overall JC; de Miranda P
    Am J Med; 1982 Jul; 73(1A):125-31. PubMed ID: 7102699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural history of neonatal herpes simplex virus infections in the acyclovir era.
    Kimberlin DW; Lin CY; Jacobs RF; Powell DA; Frenkel LM; Gruber WC; Rathore M; Bradley JS; Diaz PS; Kumar M; Arvin AM; Gutierrez K; Shelton M; Weiner LB; Sleasman JW; de Sierra TM; Soong SJ; Kiell J; Lakeman FD; Whitley RJ;
    Pediatrics; 2001 Aug; 108(2):223-9. PubMed ID: 11483781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Species differences in the disposition of acyclovir.
    de Miranda P; Krasny HC; Page DA; Elion GB
    Am J Med; 1982 Jul; 73(1A):31-5. PubMed ID: 7102710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acyclovir for chronic mucocutaneous herpes simplex virus infection in immunosuppressed patients.
    Straus SE; Smith HA; Brickman C; de Miranda P; McLaren C; Keeney RE
    Ann Intern Med; 1982 Mar; 96(3):270-7. PubMed ID: 7059087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overview of acyclovir pharmacokinetic disposition in adults and children.
    Blum MR; Liao SH; de Miranda P
    Am J Med; 1982 Jul; 73(1A):186-92. PubMed ID: 7048911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acyclovir treatment of cutaneous herpes in guinea pigs and herpes encephalitis in mice.
    Collins P; Oliver NM
    Am J Med; 1982 Jul; 73(1A):96-9. PubMed ID: 7102714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acyclovir clinical pharmacology. An overview.
    Lietman PS
    Am J Med; 1982 Jul; 73(1A):193-6. PubMed ID: 7048912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic fate of radioactive acyclovir in humans.
    de Miranda P; Good SS; Krasny HC; Connor JD; Laskin OL; Lietman PS
    Am J Med; 1982 Jul; 73(1A):215-20. PubMed ID: 7102704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.